New herbal hope for diabetics!

Image
Press Trust of India Lucknow
Last Updated : Oct 27 2015 | 10:57 AM IST
For those having high blood sugar levels and are on antibiotics for long, state-owned National Botanical Garden Institute (NBRI) here has come up with a herbal and healthy option.
"We have developed a medicine for Type-II diabetes patients on Ayurvedic method, which does not have any side effect," Senior Principal Scientist A K S Rawat told PTI today.
Generally antigens affect body organs on the long run. But this drug contains anti-oxidants, which help in rebuilding process, he said.
Rawat said the initiative was taken by NBRI Director C S Nautiyal.
He said the drug has been introduced in tablet form. The Ayurvedic drug has been named 'BGR-34' and may cost Rs 500 for 100 tablets.
"If taken for a longer period, it may also reduce dependence on insulin," Rawat said.
A combination of natural extracts, the drug has been jointly developed by two CSIR laboratories -- NBRI and the Central Institute for Medicinal and Aromatic Plant (CIMAP) -- both in Lucknow.
NBRI has given permission to a Delhi-based pharmaceutical firm for commercial manufacturing and marketing of the medicine.
"The drug has extracts from four plants mentioned in Ayurveda and that makes it safe," Rawat said.
He said tests carried on animals and related scientific study found it to be safe and effective with clinical trials showing 67 per cent success.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 27 2015 | 10:57 AM IST

Next Story